scispace - formally typeset
A

Arthur I. Cederbaum

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  375
Citations -  27906

Arthur I. Cederbaum is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Oxidative stress & Lipid peroxidation. The author has an hindex of 73, co-authored 375 publications receiving 26362 citations. Previous affiliations of Arthur I. Cederbaum include City University of New York & Rutgers University.

Papers
More filters
Journal ArticleDOI

Effect of chronic ethanol consumption on microsomal lipid peroxidation. Role of iron and comparison between controls.

TL;DR: The variabilities associated with the different controls and the role and content of transition metals such as iron probably contribute towards the divergent effects of ethanol on lipid peroxidation.
Journal ArticleDOI

NADH-dependent microsomal interaction with ferric complexes and production of reactive oxygen intermediates.

TL;DR: Results indicate that NADH can support microsomal reduction of ferric chelates, with the subsequent production of .OH-like species and peroxidation of lipids.
Journal ArticleDOI

Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism.

TL;DR: Freshly isolated hepatocytes are more susceptible to the inhibitory action of ethanol on the JAK-STAT signaling than cultured hepatocytes or HepG2 cells, which may be implicated in pathogenesis and progression of alcoholic liver disease.
Journal ArticleDOI

Role of cytochrome P-450 IIE1 and catalase in the oxidation of acetonitrile to cyanide.

TL;DR: A role for P-450 in the oxidation of acetonitrile to cyanide is implicate and it is suggested that P- 450 IIE1 may be an especially effective catalyst for this oxidation.
Journal ArticleDOI

Effect of chronic clofibrate administration on mitochondrial fatty acid oxidation.

TL;DR: It is unlikely that the hypolipidemic effects of clofibrate are mediated by reducing fatty acyl substrate levels via enhanced fatty acid oxidation, as evidence by unchanged respiratory control, ADP/O ratio, ATP− 32 P exchange reaction, and substrate- or ATP-supported Ca 2+ uptake.